This announcement is a separate document:
九典制药：关于公司2022年限制性股票激励计划调整相关事项、作废部分限制性股票及第二个归属期归属条件成就的法律意见书
Hunan Jiudian Pharmaceutical: Legal opinion on matters relating to the adjustment of the company's 2022 restricted stock incentive plan, the abolition of some restricted shares, and the achievement of ownership conditions during the second vesting period
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.